China approves Sinovac Biotech Covid-19 vaccine for general public use
FILE PHOTO: A medical worker holds a dose of the Sinovac’s vaccine at a district health facility as Indonesia begins mass vaccination for the coronavirus disease (Covid-19), starting with its healthcare workers, in Jakarta, Indonesia January 14, 2021. REUTERS/Willy Kurniawan/File Photo
BEIJING — Sinovac Biotech said on Saturday that its unit’s Covid-19 vaccine has been formally approved for use by the general public by China’s medical products regulator.
Prior to the approval, the CoronaVac vaccine had already been administered in China’s vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
JPV
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
